Showing results (171-180 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|February 1, 2005
Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patientsGeorge Beatty, James Chu, Krishnaji Kulkarni, et al.
HIV Clinical Trials|April 19, 2011
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysisSusan Swindells, Hongyu Jiang, A Lisa Mukherjee, et al.
HIV Clinical Trials|April 19, 2011
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, CanadaNisha Andany, Janet M Raboud, Sharon Walmsley, et al.
HIV Clinical Trials|April 19, 2011
Interferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4+ T-cells increase in a patient with AIDSYing Wen, Pei Liu
HIV Clinical Trials|June 21, 2011
Potential strategies for an HIV infection cureAlain Lafeuillade
HIV Clinical Trials|September 12, 2015
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot studyJordan E Lake, Sophie Seang, Theodoros Kelesidis, et al.
HIV Clinical Trials|January 6, 2016
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase InhibitorsLeonardo Calza, Ilaria Danese, Eleonora Magistrelli, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
HIV Clinical Trials|October 29, 2014
Dolutegravir: clinical and laboratory safety in integrase inhibitor-naive patientsL Curtis, G Nichols, C Stainsby, et al.
HIV Clinical Trials|September 15, 2015
Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravirRobert Cuffe, Carly Barnett, Catherine Granier, et al.
Pageof 68